Pill Identifier App

SANDOZ 619 (Rivastigmine 3 mg)

Pill imprint SANDOZ 619 has been identified as Rivastigmine tartrate 3 mg.

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease; lewy body dementia and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for SANDOZ 619

Rivastigmine tartrate 3 mg SANDOZ 619
Rivastigmine tartrate
Imprint:
SANDOZ 619
Strength:
3 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-2615
Inactive Ingredients:
gelatin
hypromellose
magnesium stearate
microcrystalline cellulose
ferric oxide red
silicon dioxide
titanium dioxide
ferric oxide yellow

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)